The Cost of Drugs: Generic or Maybe Not….

Posted by & filed under Accounting Information Systems, Accounting Principles, Advanced Accounting, All Articles, Auditing, Cost Accounting, Ethical Dilemma, Financial Accounting, Intermediate Accounting, Managerial Accounting, Uncategorized.

The standard advice for consumers is: if you are prescribed a medicine, always ask if there is a cheaper generic. Questions: 1. According to the article, why are consumers told the opposite on some drugs – take name brand drugs and pay a higher co-pay? 2. What does Dr. Diller mean by “It’s Alice-in-Wonderland time… Read more »

Mylan Settles with the Government

Posted by & filed under Accounting Information Systems, Accounting Principles, Advanced Accounting, Auditing, Cost Accounting, Ethical Dilemma, Financial Accounting, Intermediate Accounting, Managerial Accounting, Video Updates.

According to the New York Times, Mylan, the maker of the allergy treatment EpiPen, said Friday that it had reached a $465 million settlement with the Justice Department and other government agencies over questions on whether the company had overcharged Medicaid for the treatment by improperly classifying it as a generic drug. Questions: 1. What… Read more »

Submarine Patents: What is their Role?

Posted by & filed under Accounting Information Systems, Accounting Principles, Advanced Accounting, All Articles, Auditing, Cost Accounting, Ethical Dilemma, Financial Accounting, Intermediate Accounting, Managerial Accounting.

Humira and Enbrel are biologic drugs, composed of complex proteins made in living cells. Humira was the No. 1 selling biologic with $14 billion in global sales and Enbrel was the No. 3 biologic at $8.7 billion. Questions: 1. Approximately how much is the yearly price tag for these drugs per patient? 2. During the… Read more »

“A Very Dangerous Process”

Posted by & filed under Accounting Information Systems, Accounting Principles, Advanced Accounting, Auditing, Cost Accounting, Ethical Dilemma, Financial Accounting, Fraud Accounting, Intermediate Accounting, International Accounting, Managerial Accounting.

Specialists in infectious disease are protesting a gigantic overnight increase in the price of Daraprim,a 62-year-old drug that is the standard of care for treating malaria and toxoplasmosis. Questions: 1. What are the causes of price increases for drugs like Daraprim? 2. What is the past controversy associated with Martin Shkreli, the founder and chief… Read more »